Public, NASDAQ:MBRX
NASDAQ Global Market
Metabasis Announces Conference Call and Live Webcast to Discuss Second Quarter 2008 Financial Results
Date: Thu, 17 Jul 2008 17:28:29 GMT
Tags:
Metabasis Announces Conference Call and Live Webcast to Discuss Second Quarter 2008 Financial Results
MarketWatch - Jul 17, 2008
MarketWatch - Jul 17, 2008
, , ) will announce its second quarter 2008 earnings results on Thursday , August 7 , 2008 , after markets close.Following the earnings release , Metabasis will hold a conference call and live ...
Metabasis to Present at the Collins Stewart 4 th Annual Growth Conference
Date: Tue, 01 Jul 2008 17:14:23 GMT
Tags:
Metabasis to Present at the Collins Stewart 4 th Annual Growth Conference
Business Wire (press release) - Jul 1, 2008
Business Wire (press release) - Jul 1, 2008
SAN DIEGO - - ( BUSINESS WIRE ) - - Metabasis Therapeutics ( Nasdaq : MBRX ) , announced today that Dr . Paul Laikind , president and chief executive officer , will present at the Collins Stewart ...
Metabasis Sees Promising Results in Hyperlipidemia Trial
Date: Wed, 25 Jun 2008 15:04:30 GMT
Tags:
Metabasis Sees Promising Results in Hyperlipidemia Trial
FDA news (subscription) - Jun 25, 2008
FDA news (subscription) - Jun 25, 2008
Metabasis Therapeutics reported results of its Phase Ib clinical trial in subjects with high cholesterol using its drug MB07811.Thyroid hormone receptor ( TR ) agonists may be an important approach ...
Metabasis Announces Promising Results from its Phase 1b Clinical Trial for Treatment of Hyperlipidemia
Date: Tue, 24 Jun 2008 12:01:34 GMT
Tags:
Metabasis Announces Promising Results from its Phase 1b Clinical Trial for Treatment of Hyperlipidemia
ADMET.net (press release) - Jun 24, 2008
ADMET.net (press release) - Jun 24, 2008
Metabasis Therapeutics , Inc . has announced the results of its 14 - day , Phase 1b multiple - dose clinical trial in subjects with mild hypercholesterolemia , which showed that MB07811 was safe ...
Metabasis Announces Promising Results from Its Phase 1b Clinical Trial for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia
Date: Fri, 20 Jun 2008 15:12:02 GMT
Tags:
Metabasis Announces Promising Results from Its Phase 1b Clinical Trial for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia
Centre Daily Times - Jun 20, 2008
Centre Daily Times - Jun 20, 2008
SAN DIEGO - Metabasis Therapeutics , Inc . ( Nasdaq : MBRX ) announced today the results of its 14 - day , Phase 1b multiple - dose clinical trial in subjects with mild hypercholesterolemia , ...
Metabasis Therapeutics Earnings Call scheduled for Thu, Aug 7 (CCBN)
Date: Thu, 17 Jul 2008 18:10:45 Etc/GMT
Tags:
Metabasis Announces Conference Call and Live Webcast to Discuss Second Quarter 2008 Financial Results (Business Wire)
Date: Thu, 17 Jul 2008 17:14:00 Etc/GMT
Tags:
SAN DIEGO----Metabasis Therapeutics, will announce its second quarter 2008 earnings results on Thursday, August 7, 2008, after markets close. Following the earnings release, Metabasis will hold a conference call and live webcast at 4:30 p.m.
Metabasis to Present at the Collins Stewart 4th Annual Growth Conference (Business Wire)
Date: Tue, 1 Jul 2008 16:59:00 Etc/GMT
Tags:
Metabasis Announces Promising Results from Its Phase 1b Clinical Trial for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia (Business Wire)
Date: Thu, 19 Jun 2008 11:30:00 Etc/GMT
Tags:
SAN DIEGO----Metabasis Therapeutics, Inc. announced today the results of its 14-day, Phase 1b multiple-dose clinical trial in subjects with mild hypercholesterolemia, which showed that MB07811 was safe and well tolerated across the seven doses tested, ranging from 0.25 mg up to 40 mg.
Metabasis to Present at the Jefferies 2nd Annual Healthcare Conference (Business Wire)
Date: Mon, 16 Jun 2008 15:59:00 Etc/GMT
Tags:
SAN DIEGO----Metabasis Therapeutics , announced today that Dr. Paul Laikind, president and chief executive officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York, NY.